Biorasi Acquires European CRO, Advanced Biosciences Research
Leading Global CRO Expands into Western Europe, Establishes its European Headquarters in Frankfurt, Germany
Biorasi LLC, award-winning global CRO, announced today that it has completed the acquisition of Advanced Biosciences Research (ABR), a leading European CRO with operations in United Kingdom, Germany, Switzerland, and Sweden. ABR is a highly integrated group that has provided Phase II to IV clinical research project management, monitoring, and regulatory outsourcing for its sponsors in the region.
"This move is strategically crucial to addressing the ever-increasing demand for delivering Clinical Research Optimized™ globally," explained Dr. Boris Reznik, Chairman of Biorasi. "Our ProAct+™ platform is the foundation of unparalleled global integration of our project operations. It guides, adapts and improves every clinical trial planning and execution process. Expanding our Western European Operations dramatically increases its optimization capability."
"We have been working with Biorasi for over a year and have been extremely impressed with the superiority of Biorasi's innovative clinical research project delivery model. Its ProAct+™ platform does not have equals in our industry." explained Dr. Tigran Arzumanov, ABR Principle. "We are excited to be a part of Biorasi's team."
Biorasi has been running world-wide clinical trials for over a decade.It has maintained a formidable presence in North and South America, Eastern Europe and Asia. The addition of ABR's regional base to Biorasi unmatched strength in Russia and Ukraine, and a decade-long established presence in Czech Republic, Poland, Serbia, Latvia, and United Kingdom, creates a very strong footprint throughout Europe.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
